Medical Device Companies Face 2.3 Percent Excise Tax on Revenue in…
HA&W's Ori Epstein offers strategies to navigate effectively the new Medical Device Excise Tax at a joint meeting of SCBIO, SCMedTech and SEMDA on September 13, 2012
(PRWeb September 11, 2012)
Read the full story at http://www.prweb.com/releases/2012/9/prweb9887279.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.